Evidence map›Paper›PMID 27846234›Full record

Observational studyPLoS medicine2016

Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study.

International Ebola Response Team, Junerlyn Agua-Agum, Archchun Ariyarajah, Bruce Aylward, Luke Bawo, Pepe Bilivogui, Isobel M Blake, Richard J Brennan, Amy Cawthorne, Eilish Cleary and 53 more

Abstract readObservational Study
In one paragraph

Observational study in PLoS medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

63 authors.

International Ebola Response Team
Junerlyn Agua-AgumWorld Health Organization, Geneva, Switzerland.
Archchun AriyarajahWorld Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-0242-0186
Bruce AylwardWorld Health Organization, Geneva, Switzerland.
Luke BawoMinistry of Health, Monrovia, Liberia.
Pepe BilivoguiMinistry of Health, Conakry, Guinea.ORCID http://orcid.org/0000-0002-2656-8302
Isobel M BlakeMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Richard J BrennanWorld Health Organization, Geneva, Switzerland.
Amy CawthorneWorld Health Organization, Freetown, Sierra Leone.
Eilish ClearyWorld Health Organization, Freetown, Sierra Leone.
Peter ClementWorld Health Organization, Monrovia, Liberia.
Roland ContehMinistry of Health, Freetown, Sierra Leone.
Anne CoriMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Foday DafaeMinistry of Health, Freetown, Sierra Leone.
Benjamin DahlCenters for Disease Control and Prevention, Conakry, Guinea.
Jean-Marie DangouWorld Health Organization, Conakry, Guinea.
Boubacar DialloWorld Health Organization, Conakry, Guinea.
Christl A DonnellyMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Ilaria DorigattiMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.ORCID http://orcid.org/0000-0001-9959-0706
Christopher DyeWorld Health Organization, Geneva, Switzerland.
Tim EckmannsWorld Health Organization, Geneva, Switzerland.
Mosoka FallahMinistry of Health, Monrovia, Liberia.
Neil M FergusonMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-1154-8093
Lena FiebigDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Christophe FraserMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Tini GarskeMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Lice GonzalezWorld Health Organization, Monrovia, Liberia.
Esther HamblionWorld Health Organization, Monrovia, Liberia.
Nuha HamidWorld Health Organization, Monrovia, Liberia.
Sara HerseyCenters for Disease Control and Prevention, Freetown, Sierra Leone.ORCID http://orcid.org/0000-0003-4195-8517
Wes HinsleyMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Amara JambeiMinistry of Health, Freetown, Sierra Leone.
Thibaut JombartMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
David KargboMinistry of Health, Freetown, Sierra Leone.
Sakoba KeitaMinistry of Health, Conakry, Guinea.
Michael KinzerCenters for Disease Control and Prevention, Conakry, Guinea.
Fred Kuti GeorgeWorld Health Organization, Freetown, Sierra Leone.
Beatrice GodefroyWorld Health Organization, Geneva, Switzerland.
Giovanna GutierrezWorld Health Organization, Geneva, Switzerland.
Niluka KannangarageWorld Health Organization, Geneva, Switzerland.
Harriet L MillsMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Thomas MollerEuropean Centre for Disease Prevention and Control, Conakry, Guinea.
Sascha MeijersWorld Health Organization, Geneva, Switzerland.
Yasmine MohamedWorld Health Organization, Geneva, Switzerland.
Oliver MorganCenters for Disease Control and Prevention, Freetown, Sierra Leone.ORCID http://orcid.org/0000-0002-8048-5663
Gemma Nedjati-GilaniMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.ORCID http://orcid.org/0000-0001-5723-5028
Emily NewtonWorld Health Organization, Geneva, Switzerland.
Pierre NouvelletMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Tolbert NyenswahMinistry of Health, Monrovia, Liberia.
William PereaWorld Health Organization, Conakry, Guinea.
Devin PerkinsWorld Health Organization, Geneva, Switzerland.
Steven RileyMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Guenael RodierWorld Health Organization, Conakry, Guinea.ORCID http://orcid.org/0000-0002-8618-7392
Marc RondyEpiconcept, Conakry, Guinea.
Maria SagradoWorld Health Organization, Geneva, Switzerland.
Camelia SavulescuEpiconcept, Conakry, Guinea.
Ilana J SchaferCenters for Disease Control and Prevention, Freetown, Sierra Leone.
Dirk SchumacherWorld Health Organization, Geneva, Switzerland.
Thomas SeylerEpiconcept, Conakry, Guinea.
Anita ShahWorld Health Organization, Geneva, Switzerland.
Maria D Van KerkhoveMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
C Samford WessehMinistry of Health, Monrovia, Liberia.
Zabulon YotiWorld Health Organization, Freetown, Sierra Leone.

Funding

Models for synthesising molecular, clinical and epidemiological data, and translaU01GM110721 · NIGMS · IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE · PI CAUCHEMEZ, SIMON, FERGUSON, NEIL MORRIS · 2014 to 2018
$1.9M
Medical Research Council G0800596Medical Research Council MR/J008761/1Medical Research Council MR/K010174/1NIGMS NIH HHS U01 GM110721World Health Organization 001
6 · The paper itself

Abstract

backgroundThe ongoing West African Ebola epidemic began in December 2013 in Guinea, probably from a single zoonotic introduction. As a result of ineffective initial control efforts, an Ebola outbreak of unprecedented scale emerged. As of 4 May 2015, it had resulted in more than 19,000 probable and confirmed Ebola cases, mainly in Guinea (3,529), Liberia (5,343), and Sierra Leone (10,746). Here, we present analyses of data collected during the outbreak identifying drivers of transmission and highlighting areas where control could be improved. METHODS AND

findingsOver 19,000 confirmed and probable Ebola cases were reported in West Africa by 4 May 2015. Individuals with confirmed or probable Ebola ("cases") were asked if they had exposure to other potential Ebola cases ("potential source contacts") in a funeral or non-funeral context prior to becoming ill. We performed retrospective analyses of a case line-list, collated from national databases of case investigation forms that have been reported to WHO. These analyses were initially performed to assist WHO's response during the epidemic, and have been updated for publication. We analysed data from 3,529 cases in Guinea, 5,343 in Liberia, and 10,746 in Sierra Leone; exposures were reported by 33% of cases. The proportion of cases reporting a funeral exposure decreased over time. We found a positive correlation (r = 0.35, p < 0.001) between this proportion in a given district for a given month and the within-district transmission intensity, quantified by the estimated reproduction number (R). We also found a negative correlation (r = -0.37, p < 0.001) between R and the district proportion of hospitalised cases admitted within ≤4 days of symptom onset. These two proportions were not correlated, suggesting that reduced funeral attendance and faster hospitalisation independently influenced local transmission intensity. We were able to identify 14% of potential source contacts as cases in the case line-list. Linking cases to the contacts who potentially infected them provided information on the transmission network. This revealed a high degree of heterogeneity in inferred transmissions, with only 20% of cases accounting for at least 73% of new infections, a phenomenon often called super-spreading. Multivariable regression models allowed us to identify predictors of being named as a potential source contact. These were similar for funeral and non-funeral contacts: severe symptoms, death, non-hospitalisation, older age, and travelling prior to symptom onset. Non-funeral exposures were strongly peaked around the death of the contact. There was evidence that hospitalisation reduced but did not eliminate onward exposures. We found that Ebola treatment units were better than other health care facilities at preventing exposure from hospitalised and deceased individuals. The principal limitation of our analysis is limited data quality, with cases not being entered into the database, cases not reporting exposures, or data being entered incorrectly (especially dates, and possible misclassifications).

conclusionsAchieving elimination of Ebola is challenging, partly because of super-spreading. Safe funeral practices and fast hospitalisation contributed to the containment of this Ebola epidemic. Continued real-time data capture, reporting, and analysis are vital to track transmission patterns, inform resource deployment, and thus hasten and maintain elimination of the virus from the human population.

Indexed as

Disease OutbreaksEbolavirusGuineaHemorrhagic Fever, EbolaHumansLiberiaRetrospective StudiesRisk FactorsSierra Leone

Identifiers

PMID27846234
PMCPMC5112802

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.